Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo - PubMed (original) (raw)
. 1997 Apr 3;386(6624):510-4.
doi: 10.1038/386510a0.
Affiliations
- PMID: 9087412
- DOI: 10.1038/386510a0
Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
H E Farrell et al. Nature. 1997.
Abstract
Herpesviruses, such as murine and human cytomegalovirus (MCMV and HCMV), can establish a persistent infection within the host and have diverse mechanisms as protection from host immune defences. Several herpesvirus genes that are homologous to host immune modulators have been identified, and are implicated in viral evasion of the host immune response. The discovery of a viral major histocompatibility complex (MHC) class I homologue, encoded by HCMV, led to speculation that it might function as an immune modulator and disrupt presentation of peptides by MHC class I to cytotoxic T cells. However, there is no evidence concerning the biological significance of this gene during viral infection. Recent analysis of the MCMV genome has also demonstrated the presence of a MHC class I homologue. Here we show that a recombinant MCMV, in which the gene encoding the class I homologue has been disrupted, has severely restricted replication during the acute stage of infection compared with wild-type MCMV. We demonstrate by in vivo depletion studies that natural killer (NK) cells are responsible for the attenuated phenotype of the mutant. Thus the viral MHC class I homologue contributes to immune evasion through interference with NK cell-mediated clearance.
Comment in
- Viral decoy vetoes killer cell.
Kärre K, Welsh RM. Kärre K, et al. Nature. 1997 Apr 3;386(6624):446-7. doi: 10.1038/386446a0. Nature. 1997. PMID: 9087399 No abstract available.
Similar articles
- The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
Reyburn HT, Mandelboim O, Valés-Gómez M, Davis DM, Pazmany L, Strominger JL. Reyburn HT, et al. Nature. 1997 Apr 3;386(6624):514-7. doi: 10.1038/386514a0. Nature. 1997. PMID: 9087413 - Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144.
Kubota A, Kubota S, Farrell HE, Davis-Poynter N, Takei F. Kubota A, et al. Cell Immunol. 1999 Feb 1;191(2):145-51. doi: 10.1006/cimm.1998.1424. Cell Immunol. 1999. PMID: 9973537 - MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.
Krmpotić A, Busch DH, Bubić I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjić S. Krmpotić A, et al. Nat Immunol. 2002 Jun;3(6):529-35. doi: 10.1038/ni799. Epub 2002 May 20. Nat Immunol. 2002. PMID: 12021778 - Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match.
Webb JR, Lee SH, Vidal SM. Webb JR, et al. Genes Immun. 2002 Aug;3(5):250-62. doi: 10.1038/sj.gene.6363876. Genes Immun. 2002. PMID: 12140743 Review. - Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin A, Xu H, Yan W. Lin A, et al. Cell Mol Immunol. 2007 Apr;4(2):91-8. Cell Mol Immunol. 2007. PMID: 17484802 Review.
Cited by
- Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene.
Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW. Leib DA, et al. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6097-101. doi: 10.1073/pnas.100415697. Proc Natl Acad Sci U S A. 2000. PMID: 10801979 Free PMC article. - NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.
Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak-Pugel E, Messerle M, Hengel H, Busch DH, Koszinowski UH, Jonjic S. Krmpotic A, et al. J Exp Med. 2005 Jan 17;201(2):211-20. doi: 10.1084/jem.20041617. Epub 2005 Jan 10. J Exp Med. 2005. PMID: 15642742 Free PMC article. - A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection.
Crumpler MM, Choi KY, McVoy MA, Schleiss MR. Crumpler MM, et al. Vaccine. 2009 Jun 24;27(31):4209-18. doi: 10.1016/j.vaccine.2009.04.036. Epub 2009 May 3. Vaccine. 2009. PMID: 19389443 Free PMC article. - Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.
Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, Sedmak DD. Miller DM, et al. J Exp Med. 1998 Mar 2;187(5):675-83. doi: 10.1084/jem.187.5.675. J Exp Med. 1998. PMID: 9480977 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials